Glucagon controls obesity-specific energy expenditure via persistent cAMP/PKA signaling.

Saved in:
Bibliographic Details
Title: Glucagon controls obesity-specific energy expenditure via persistent cAMP/PKA signaling.
Authors: Long F; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland., Challa TD; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland., Ding L; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland., Sharma AK; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland., Wu C; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland., Ghosh A; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland., Noé F; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland., Horvath C; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland., Liebisch G; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital of Regensburg, 93053 Regensburg, Germany., Höring M; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital of Regensburg, 93053 Regensburg, Germany., Wang T; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland., Klug M; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland., Zimmermann T; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Pereira MMA; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Rist W; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Strobel B; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Pekcec A; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Neubauer H; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Wolfrum C; Laboratory of Translational Nutrition Biology, Institute of Food Nutrition and Health, Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland. Electronic address: christian-wolfrum@ethz.ch.
Source: Journal of hepatology [J Hepatol] 2025 Dec; Vol. 83 (6), pp. 1379-1391. Date of Electronic Publication: 2025 Jun 21.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1600-0641
DOI:10.1016/j.jhep.2025.06.011